Dosing Guide

Mounjaro Dose Schedule Guide

Quick Answer: Mounjaro treatment begins at 2.5 mg once weekly and increases every four weeks through 5 mg, 7.5 mg, 10 mg and 12.5 mg before reaching the maximum maintenance dose of 15 mg at approximately week 21. Not all patients need to reach 15 mg — some achieve excellent results at 10 mg or 12.5 mg.
6 stepsin the Mounjaro dose escalation schedule
20 weeksto reach 15 mg maintenance dose
15 mgmaximum licensed maintenance dose — best efficacy
Full Escalation Chart Mounjaro Dose Escalation Schedule The full Mounjaro dosing schedule from first injection to maintenance, reflecting MHRA-approved prescribing information and NICE TA1026. Note: Mounjaro has six steps versus Wegovy's four, and a longer escalation period — 20 weeks versus 16 weeks. Not all patients need to reach 15 mg.
DoseTimelinePurposeSide EffectsStage
2.5 mgWeeks 1–4Tolerability dose — body adjustmentMild nausea possibleEscalation
5 mgWeeks 5–8First escalationNausea may increase; diarrhoea commonEscalation
7.5 mgWeeks 9–12Second escalationPeak nausea period for most patientsEscalation
10 mgWeeks 13–16Third escalationGI settling; appetite markedly reducedEscalation
12.5 mgWeeks 17–20Fourth escalationNausea reducing; body well adaptedEscalation
15 mgWeek 21+MaintenanceSide effects substantially settledMaintenance
Missed Dose Guide
ScenarioWhat to Do
Missed dose — 4 days or fewer have passedTake the missed dose as soon as you remember. Resume your usual weekly day.
Missed dose — more than 4 days have passedSkip the missed dose entirely. Take next dose on usual scheduled day. Do not double up.
Missed multiple doses (1–2 weeks)Resume on normal schedule. Expect a temporary return of side effects.
Extended break (4+ weeks)Contact your prescribing clinician — a dose reduction and re-escalation is likely required.
Important: Mounjaro has a shorter half-life (~5 days) than Wegovy (~7 days), meaning blood concentrations fall more quickly between injections. Maintaining a consistent weekly injection schedule is particularly important for sustained appetite suppression.
Clinical Outcomes by Dose Weight Loss at Each Maintenance Dose
Maintenance DoseAvg Weight Loss (SURMOUNT-1, 72 wks)Typical Patient Profile
10 mg~19.5%Patients who find higher doses cause persistent GI symptoms; good responders at this level
12.5 mg~20.9%Near-maximum efficacy with better tolerability for some; penultimate step
15 mg~22.5%Standard maintenance target; recommended for all patients who can tolerate full escalation
FAQs Frequently Asked Questions
Mounjaro treatment begins at 2.5 mg once weekly for four weeks, then increases every four weeks through 5 mg, 7.5 mg, 10 mg and 12.5 mg before reaching the maximum maintenance dose of 15 mg at approximately week 21. All doses are administered as a once-weekly subcutaneous injection.
Mounjaro doses are increased every four weeks under the standard schedule. This interval allows the body's GLP-1 and GIP receptors to adapt to each dose level before stimulation is increased further. Some patients follow a slower six- or eight-week schedule.
Yes — remaining at 10 mg or 12.5 mg is clinically acceptable when 15 mg causes intolerable side effects despite dietary management. Both doses produce clinically meaningful weight loss. However, a slower escalation schedule — spending six or eight weeks at each step — is usually preferable to permanently staying below maximum dose.
The starting dose of Mounjaro is 2.5 mg once weekly. This is a tolerability dose rather than a full therapeutic dose — it is designed to allow the body to adjust to tirzepatide before escalation begins. Most patients find the starting dose well tolerated.
The maximum licensed dose of Mounjaro is 15 mg once weekly. This is also the maintenance dose and produces the highest average weight loss — approximately 22.5% of body weight over 72 weeks in SURMOUNT-1.
If fewer than four days have passed since your missed dose, take it as soon as you remember. If more than four days have passed, skip it and resume on your usual schedule. Never double up. After an extended break of four or more weeks, contact your prescribing clinician as a dose reduction may be required.
Ready to Start Mounjaro Treatment? GPhC-registered pharmacy (No. 9012585) · UK-licensed prescribers · Free online assessment Check Your Eligibility →
Jastreboff AM et al. SURMOUNT-1. N Engl J Med. 2022. Mounjaro SmPC. Eli Lilly. 2023. NICE TA1026. 2024. Happy Pharmacy (GPhC No. 9012585). Educational purposes only.